Although POCUS measures gastric content as a surrogate for aspiration risk, it is a validated, guideline-endorsed tool, supported by multiple studies and recommended by the ASA for perioperative risk assessment [10,11,12,13,14,15,16,17,18,19,20,21, 23]
Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer
Dosage adjustments may be necessary
While substantial weight loss may indirectly improve cortisol metabolism through reduced adiposity, the medication cannot override the effects of chronic psychological stress
Weekly injection patients in major trials showed better weight loss and adherence when they maintained a fixed schedule rather than attempting compensatory dosing
People taking these drugs have seen improvements in their blood pressure, cholesterol, and triglyceride levels, though its not clear whether these benefits are from the medicine or the weight loss